Earnings Feed
Start Free
Home/Insiders/ZACCARDELLI DAVID
ZD
SEC Insider//CIK 0001627642

ZACCARDELLI DAVID

CIK 00016276426 companiesBOSTON, MA
SEC Profile

Transactions

50

Companies

6

Filings

7

CIK

0001627642

Recent Transactions

50 trades
  • Award
    Vor Biopharma Inc.$VOR

    Stock Option (Right to Buy)

    2026-07-07+42,658→ 42,658 total
  • Award
    SAB Biotherapeutics, Inc.$SABS

    Stock Option (right to buy)

    2026-01-05+240,000→ 240,000 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07+3,285,280→ 3,285,280 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−12,176,144→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−1,649,952→ 0 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07+1,649,952→ 1,649,952 total
  • Disposition to Issuer
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-10-07−3,285,280→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−445,536→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−389,792→ 0 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Unit

    2025-10-07−800,000→ 0 total
  • Gift
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-29−1,200,000→ 12,176,144 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−55,696→ 389,792 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Stock Units

    2025-08-01−200,000→ 800,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01$13.14/sh−208,912→ 13,376,144 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-08-01+255,696→ 13,585,056 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-08$11.44/sh−90,320→ 13,329,360 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07−229,512→ 445,536 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-07-07+229,512→ 13,419,680 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-07-07+675,048→ 675,048 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-06-11$11.40/sh−400,000→ 13,190,168 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-29$9.33/sh−208,696→ 13,590,168 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-28$9.30/sh−157,704→ 13,798,864 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-27$9.53/sh−33,600→ 13,956,568 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-02$9.09/sh−400,000→ 13,990,168 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-05-01−200,000→ 1,000,000 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−108,272→ 14,268,904 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01+200,000→ 14,468,904 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-05-01$8.95/sh−78,736→ 14,390,168 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29$8.98/sh−90,360→ 14,377,176 total
  • Award
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29+675,000→ 675,000 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-04-29+229,512→ 14,467,536 total
  • Exercise/Conversion
    Verona Pharma plc$VRNA

    Restricted Share Units

    2025-04-29−229,512→ 445,488 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-03$7.16/sh−166,728→ 14,238,024 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2025-02-01+200,000→ 14,404,752 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-06$5.01/sh−162,800→ 14,204,752 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-05$5.01/sh−640,264→ 14,367,552 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-04$5.00/sh−67,608→ 15,007,816 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-12-02$5.00/sh−3,200→ 15,075,424 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-29$5.01/sh−98,888→ 15,078,624 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-27$5.00/sh−23,240→ 15,177,512 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-25$5.00/sh−1,600→ 15,200,752 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-11$5.00/sh−2,400→ 15,202,352 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-04$4.39/sh−94,144→ 15,204,752 total
  • Tax Payment
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01$4.24/sh−245,952→ 15,345,784 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01+200,000→ 15,591,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-11-01$4.38/sh−46,888→ 15,298,896 total
  • Award
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-30+800,000→ 15,391,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-25$4.38/sh−4,800→ 14,591,736 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-24$4.38/sh−140,000→ 14,596,536 total
  • Sale
    Verona Pharma plc$VRNA

    Ordinary Shares

    2024-10-23$4.38/sh−16→ 14,736,536 total

Companies

6

Recent Filings

7

Address

500 BOYLSTON STREET, SUITE 1350

BOSTON, MA, 02116

View on SEC.gov